JBM (Healthcare) Limited 2161.HK Open JBM (Healthcare) Limited in new tab
JBM (Healthcare) Limited Analysis (2161.HK)
Is JBM (Healthcare) Limited a good investment? JBM (Healthcare) Limited (2161.HK) is currently trading at 2.45 HKD.
In terms of valuation, the stock trades at a P/E ratio of 9.44. This relatively low multiple may signal that JBM (Healthcare) Limited is undervalued compared to historical market norms.
Earnings Schedule: JBM (Healthcare) Limited is expected to release its next earnings report on June 12, 2026.
For income investors, JBM (Healthcare) Limited pays a dividend yield of 7.53%. With a payout ratio of 64%, the dividend appears sustainable.
Investor FAQ
Does JBM (Healthcare) Limited pay a dividend?
Yes, it pays an annual dividend of 0.20 HKD (7.53% yield).
What asset class is JBM (Healthcare) Limited?
JBM (Healthcare) Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be June 12, 2026. The company currently has a trailing EPS of 0.27.
Company Profile
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other non-pharmaceutical products for the general health and wellness of consumers. The company also offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and CCMG products. It is also involved in the manufactures, trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong.
Dividend Yield
7.53%
Annual Dividends
0.20 HKD
Next ex. div date
Nov. 28, 2025
Payout Ratio
63.98%
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2026 | 0.21 HKD |
| Dec. 29, 2026 (estimated) | 0.0975 |
| Aug. 28, 2026 (estimated) | 0.1150 |
| 2025 | 0.27 HKD |
| Dec. 17, 2025 | 0.0975 |
| Aug. 28, 2025 | 0.1150 |
| Jan. 15, 2025 | 0.0550 |
| 2024 | 0.04 HKD |
| Sept. 17, 2024 | 0.0405 |
| 2023 | 0.06 HKD |
| Dec. 28, 2023 | 0.0345 |
| Sept. 1, 2023 | 0.0250 |
| 2022 | 0.01 HKD |
| Dec. 29, 2022 | 0.0050 |
Yearly aggregated dividends
Dividends
|
JBM (Healthcare) Limited
Dec 17, 2025 Paid
Dividend
0.0975 HKD |
|
JBM (Healthcare) Limited
Aug 28, 2025 Paid
Dividend
0.115 HKD |
Historical Split Corporate Actions
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion